Results 41 to 50 of about 308,174 (298)

Prevalence of XMRV Nucleic Acid and Antibody in HIV-1-Infected Men and in Men at Risk for HIV-1 Infection

open access: yesAdvances in Virology, 2011
Xenotropic MLV-Related Virus (XMRV) was recently reported to be associated with prostate cancer and chronic fatigue syndrome (CFS). Infection was also reported in 3.7% of healthy individuals.
J. Spindler   +13 more
doaj   +1 more source

Analysis of HIV-1 subtypes and drug resistance mutations in people who inject drugs in Aizawl and nearby districts of Mizoram, India

open access: yesVirulence
Over the last decade, there has been a steady increase in HIV-1 prevalence in Mizoram, India. Importantly, this increase in HIV-1 prevalence is not only limited to the key population groups such as female sex workers (FSWs) or people who inject drugs ...
Komal Raskar   +8 more
doaj   +1 more source

Antiretroviral drug use and HIV drug resistance in female sex workers in Tanzania and the Dominican Republic.

open access: yesPLoS ONE, 2020
ObjectiveFemale sex workers (FSW) have increased risk of HIV infection. Antiretroviral treatment (ART) can improve HIV outcomes and prevent HIV transmission.
Wendy Grant-McAuley   +14 more
doaj   +1 more source

Drug resistance and drug resistance gene analysis for 205 cases of pulmonary tuberculosis with HIV-infected patients

open access: yesPifu-xingbing zhenliaoxue zazhi, 2022
Objective To investigate the drug resistance and drug resistance genes in human immunodeficiency virus (HIV) -infected patients with pulmonary tuberculosis (TB) in Zhengzhou, Henan province, so as to provide reference for effective diagnosis and ...
Ge LI, Zhongfeng CUI, Xiaojiu CAO
doaj   +1 more source

High Levels of Transmitted HIV Drug Resistance in a Study in Papua New Guinea.

open access: yesPLoS ONE, 2017
IntroductionPapua New Guinea is a Pacific Island nation of 7.3 million people with an estimated HIV prevalence of 0.8%. ART initiation and monitoring are guided by clinical staging and CD4 cell counts, when available.
Evelyn Lavu   +15 more
doaj   +1 more source

Letter to the editor: Pre-exposure prophylaxis for HIV in Europe: The need for resistance surveillance [PDF]

open access: yes, 2017
__To the editor:__ In a recent paper by Hauser et al. in this journal, a prevalence of 10.8% of transmitted drugresistant viruses was reported among newly diagnosed HIV cases in Germany in 2013 and 2014.
Boucher, C.A.B. (Charles)   +4 more
core   +4 more sources

HIV-1 drug-resistance surveillance among treatment-experienced and -naïve patients after the implementation of antiretroviral therapy in Ghana. [PDF]

open access: yesPLoS ONE, 2013
BACKGROUND: Limited HIV-1 drug-resistance surveillance has been carried out in Ghana since the implementation of antiretroviral therapy (ART). This study sought to provide data on the profile of HIV-1 drug resistance in ART-experienced and newly ...
Nicholas I Nii-Trebi   +8 more
doaj   +1 more source

Reciprocal control of viral infection and phosphoinositide dynamics

open access: yesFEBS Letters, EarlyView.
Phosphoinositides, although scarce, regulate key cellular processes, including membrane dynamics and signaling. Viruses exploit these lipids to support their entry, replication, assembly, and egress. The central role of phosphoinositides in infection highlights phosphoinositide metabolism as a promising antiviral target.
Marie Déborah Bancilhon, Bruno Mesmin
wiley   +1 more source

HIV Drug Resistance

open access: yesJournal of Human Virology & Retrovirology, 2016
Submit Manuscript | http://medcraveonline.com with nonnucleoside reverse inhibitors (NNRTIs). Pre-therapy resistance is associated with first-line therapy failure. The most common viral mutations in HIV/AIDS patients with ARV drug resistance are M184/V, K103N, and M230L.
openaire   +2 more sources

Modeling long-term longitudinal HIV dynamics with application to an AIDS clinical study

open access: yes, 2009
A virologic marker, the number of HIV RNA copies or viral load, is currently used to evaluate antiretroviral (ARV) therapies in AIDS clinical trials. This marker can be used to assess the ARV potency of therapies, but is easily affected by drug exposures,
Huang, Yangxin, Lu, Tao
core   +1 more source

Home - About - Disclaimer - Privacy